These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3544349)

  • 1. Inhibition of thromboxane A2 production does not improve post-ischemic brain hypoperfusion in the dog.
    Prough DS; Kong D; Watkins WD; Stout R; Stump DA; Beamer WC
    Stroke; 1986; 17(6):1272-6. PubMed ID: 3544349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs.
    Grice SC; Chappell ET; Prough DS; Whitley JM; Su M; Watkins WD
    Stroke; 1987; 18(4):787-91. PubMed ID: 3603606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of CV-4151 on the cerebral hypoperfusion and production of thromboxane A2 following complete cerebral ischemia-reperfusion in dogs].
    Kito G; Tanabe M; Terashita Z
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):413-20. PubMed ID: 8282273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart.
    Sakai K; Ito K; Ogawa K
    J Cardiovasc Pharmacol; 1982; 4(1):129-35. PubMed ID: 6176788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats.
    Sadoshima S; Ooboshi H; Okada Y; Yao H; Ishitsuka T; Fujishima M
    Eur J Pharmacol; 1989 Oct; 169(1):75-83. PubMed ID: 2513212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition.
    Edstrom LE; Balkovich M; Slotman GJ
    Ann Plast Surg; 1988 Feb; 20(2):106-11. PubMed ID: 3281544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
    J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane synthetase inhibition in acute focal cerebral ischemia in cats.
    Moufarrij NA; Little JR; Skrinska V; Lucas FV; Latchaw JP; Slugg RM; Lesser RP
    J Neurosurg; 1984 Dec; 61(6):1107-12. PubMed ID: 6542131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain.
    Pettigrew LC; Grotta JC; Rhoades HM; Wu KK
    Stroke; 1989 May; 20(5):627-32. PubMed ID: 2718203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.
    Defreyn G; Deckmyn H; Vermylen J
    Thromb Res; 1982 Jun; 26(6):389-400. PubMed ID: 7051416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane receptor antagonism and synthase inhibition in cerebral ischemia.
    Pettigrew LC; Kryscio RJ
    Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):211-7. PubMed ID: 8469680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor.
    Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR
    Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane synthetase inhibition with imidazole increases blood flow in ischemic penumbra.
    Roy MW; Dempsey RJ; Cowen DE; Donaldson DL; Young AB
    Neurosurgery; 1988 Feb; 22(2):317-23. PubMed ID: 3162556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs.
    Matsumoto Y; Ochi H; Aihara K; Inui J; Ikegami K
    Eur J Pharmacol; 1992 Mar; 213(2):167-70. PubMed ID: 1521557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane generation after thrombin. Protective effect of thromboxane synthetase inhibition on lung fluid balance.
    Garcia-Szabo RR; Peterson MB; Watkins WD; Bizios R; Kong DL; Malik AB
    Circ Res; 1983 Aug; 53(2):214-22. PubMed ID: 6684001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.